Therefore, the NPY system could be of interest in MJD as a possible therapeutic agent, and detection of SNPs in a larger sample should be performed in the future to confirm the results and find other “missing heritability” in MJD. The gene discussed is NPY; the disease is Spinocerebellar ataxia type 3.